FOLH1 and prostate cancer: This study describes immunohistochemical PSMA-negative tumour area, infiltrative growth pattern, smaller tumour size and WHO/ISUP grade group 2 as parameters associated with lower PSMA-PET uptake in RPE specimen of primary prostate cancers.